NAFLD in type 1 diabetes: overrated or underappreciated?
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in western countries, affecting 25–30% of the general population and up to 65% in those with obesity and/or type 2 diabetes. Accumulation of visceral adipose tissue and insulin resistance (IR) contributes to NAFLD. NAF...
Saved in:
Main Authors: | Jonathan Mertens, Luc F. Van Gaal, Sven M. Francque, Christophe De Block |
---|---|
Format: | article |
Language: | EN |
Published: |
SAGE Publishing
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/309a074d7b7f4f34b4d8166ab91feff0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maturity-Onset Diabetes of Young Type 5: Diabetes with Extrapancreatic Features
by: Adnan Haider, et al.
Published: (2021) -
Cardiovascular autonomic neuropathy and the impact on progression of diabetic kidney disease in type 1 diabetes
by: Peter Rossing, et al.
Published: (2021) -
Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
by: Giesje Nefs, et al.
Published: (2021) -
Plasma protein N-glycosylation is associated with cardiovascular disease, nephropathy, and retinopathy in type 2 diabetes
by: Femke Rutters, et al.
Published: (2021) -
The Effect of Liraglutide on Epicardial Adipose Tissue in Type 2 Diabetes
by: Na Zhao, et al.
Published: (2021)